page_banner

Mayelana NATHI

I-Hangzhou Copel Chemical Co., Ltd.

I-Hangzhou Copel Chemical Co, Ltd. itholakala edolobheni elihle, i-Hangzhou City. IHangzhou Copel Chemical Co, Ltd. (ngemuva kwalokhu ebizwa ngokuthi "iCopel") ingumhlinzeki ophrofeshinali kuma-API, abaxhumanisi bezemithi, izithasiselo nezithasiselo zokudla kanye neVeterinary eChina. Okwamanje, thina lapha sigcizelela ukuthi siqine kakhulu ekukhiqizeni izinkontileka.
ICopel ithuthukise ukubambisana okuhlelekile nabakhiqizi abaningi abahle eChina. Ngokukhethekile sinemithombo emihle enenkontileka.
ICopel ithumele izinhlobo zemikhiqizo ezimakethe ezahlukahlukene. Imikhiqizo yethu kanye nensizakalo yobuchwepheshe yaneliseka kakhulu ngamakhasimende.

Ikhwalithi yokuqala

Isikweletu Kuqala

Win-Win Ukubambisana

NgoMashi 2, i-US FDA ivume isicelo esisha sezidakamizwa (i-NDA) se-AZSTARYS (igama lekhodi: KP415), kanye ngosuku, ekwelapheni ukunakekelwa kokushoda kokungasebenzi (ADHD) ezigulini ezineminyaka engu-6 nangaphezulu. Izothengiswa e-United States. Ku
I-AZSTARYS iyifomu yesilinganiso se-capsule eyakhiwe i-dexmethylphenidate (d-MPH) i-prodrug serdexmethylphenidate (SDX) kanye nokukhishwa ngokushesha kwe-d-MPH. I-AZSTARYS iqukethe i-30% ekhishwa ngokushesha i-d-MPH ne-70% ekhishwe i-SDX entsha. Ngemuva kokumunca umgudu wamathumbu, i-SDX iguqulwa ibe yi-d-MPH, kuthi i-d-MPH ikhishwe kancane kancane phakathi nosuku.
Uma kuqhathaniswa nezidakamizwa ezidayiswa njengamanje i-Vyvanse (Ridexamphetamine Dimesylate Capsules) kanye ne-Osmotic (Methylphenidate Hydrochloride Sustained Release Tablets), i-AZSTARYS inethuba lokuqala ngokushesha ngenxa yokukhishwa ngokushesha kwe-d-MPH. Uma kuqhathaniswa ne-Adderall XR (ama-amphetamine complex salt capsule-release capsule) kanye neFocalin XR (dexmethylphenidate hydrochloride capsule-release-release capsules), ngoba i-SDX iyisidakamizwa, inganciphisa ukuncika kwezidakamizwa.